2 hrs ago | KMPH-TV Fresno
Hemoglobin A1C test (HbA1C): your questions answered
Checking your blood sugar every day, sometimes several times a day, is very important.
6 hrs ago | Manitowoc Herald Times Reporter
Question: I've heard that people with diabetes need more frequent eye exams. Can you explain? Answer: Yes, people with diabetes do need more frequent exams because they have a higher risk of developing blindness than people without diabetes.
10 hrs ago | Austin American-Statesman
Coffee brims with health benefits, researchers say
Drink up, coffee lovers. Not only is coffee aromatic and delicious, it's good for you.
Denver Post Economy/Real Estate
CSU study: Insulin levels may hold dementia key
Colorado State University researchers think insulin levels in the brain may be the key to understanding how some types of dementia progress.
Low Aboriginal transplant rates blamed on 'bias and racism'
Peter Nakogee knows the chances are not good for aboriginals seeking transplants in Canada, but the gregarious father of four has reason to celebrate.
19:44 Weight/diabetes link highlighted
Almost one third of people in the Republic think they are overweight, a new survey has revealed.
Editor's note: This fall, The N&O is talking to people about the nation's health care system: what works, what doesn't and what should be done to fix it.
Pico-Tesla commences pilot study of its Resonator system for treating type 2 diabetes patients
The Pilot Study seeks to determine whether the application of magnetic fields generated by the Company's patented ResonatorTM system can be effective as an adjunctive therapy to oral medications in reducing hemoglobin A1c levels.
Islanders: Diabetes cripples and kills thousands of us; we must fight back
Diabetes continues to be one of the largest medical problems facing our community.
Amylin Pharmaceuticals And Eli Lilly And Company Statement On FDA's...
Amylin Pharmaceuticals And Eli Lilly And Company Statement On FDA's BYETTA Injection Update Main Category: Urology / Nephrology Also Included In: Diabetes ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 03 Nov 2009 - 1:00 PST Amylin Pharmaceuticals, Inc., and Eli Lilly and Company issued the following statement ...
Ossulin™ Oral Insulin Data To Be Presented At The San...
The first public data on Ossulin a new oral insulin product, will be presented today at the 9th Annual Diabetes Technology Meeting in San Francisco, CA.
Men Twice As Likely Not To Know They Have Diabetes
New research suggests men over 50 are nearly twice as likely to have undiagnosed Type 2 diabetes than their female counterparts, warns Diabetes UK today.
Health Highlights: Nov. 5, 2009
Here are some of the latest health and medical news developments, compiled by editors of HealthDay : Almost two dozen doctors have quit the American Academy of Family Physicians after the group announced a deal with Coca-Cola Co.
Criticised doctor wins new inquest after patient's death
A doctor severely criticised by a coroner over the death of a patient has won a new inquest in London before a different coroner.
Metabolex, Inc. Closes $8.6 Million Financing Round
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, today announced it had closed an additional $8.6 million in financing.
Quick, what is the main food diabetics have to avoid? If you said sugar, you're under the spell of a common health myth, according to Omaha, Neb., Hy-Vee grocery dietitian Carrie Nielsen.
Halozyme takes bigger loss on testing expenses
Biotechnology company Halozyme Therapeutics Inc. reported a bigger third-quarter loss on Friday, as it started clinical trials of a fast-acting insulin during the period.
International Diabetes Federation releases guidelines
The International Diabetes Federation has released three sets of guidelines for health providers aimed at improving patient care and stemming the growing worldwide incidence of the disease.
Clinical Trials Update: Nov. 2, 2009
Here are the latest clinical trials, courtesy of ClinicalConnection.com : Type 2 Diabetes with Acute Coronary Syndrome This study will evaluate the cardiovascular safety of an investigational medication given to type 2 diabetics with ACS.
More kids have diabetes, fewer schools have nurses
* Of those, the number diagnosed: about 18 million. * Diagnosed with type 1 diabetes: 5% to 10%. * People with pre-diabetes: about 56 million.